Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Neuromuscular Manifestations » Spasm
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Neuromuscular Manifestations » Spasm
Description
An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE. MeSH
Hierarchy View
Subtype Terms (2)
Hemifacial Spasm
5 drugs (4 approved, 1 experimental)
Trismus
20 drugs (13 approved, 7 experimental)
Approved Indicated Drugs (21)
Phase 3 Indicated Drugs (5)
Phase 2 Indicated Drugs (3)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (15)
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (20)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Other Experimental Indications (19)
Cantonal Hospital of St. Gallen
Huazhong University of Science and Technology
Institut National de la Santé Et de la Recherche Médicale, France
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
